In the US, Tolmetin (tolmetin systemic) is a member of the drug class nonsteroidal anti-inflammatory agents and is used to treat Back Pain, Gout - Acute, Inflammatory Conditions, Osteoarthritis, Pain, Rheumatoid Arthritis and Sciatica.
US matches:
- Tolmetin
- Tolmetin Sodium
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
M01AB03,M02AA21
CAS registry number (Chemical Abstracts Service)
0026171-23-3
Chemical Formula
C15-H15-N-O3
Molecular Weight
257
Therapeutic Categories
Analgesic, antipyretic and anti-inflammatory agent
Non-steroidal anti-inflammatory drug, NSAID
Chemical Name
1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-
Foreign Names
- Tolmetinum (Latin)
- Tolmetin (German)
- Tolmétine (French)
- Tolmetina (Spanish)
Generic Names
- Tolmetin (OS: BAN, USAN)
- Tolmetina (OS: DCIT)
- Tolmétine (OS: DCF)
- McN 2559 (IS: McNeil)
- Tolmetin Sodium (OS: BANM, USAN, JAN)
- McN 2559-21-98 (IS: McNeil)
- Tolmetin Sodium (PH: USP 32)
Brand Names
- Tolectin
Janssen, Cyprus; Janssen, Lebanon; Janssen, Luxembourg; Janssen, Saudi Arabia; Janssen, Syria; Janssen-Cilag, United Arab Emirates; Janssen-Cilag, Egypt; Janssen-Cilag, Jordan; Ortho-McNeil, United States - Artrocaptin
Estedi, Spain - Tolectin
Janssen, Ireland; Janssen, Mexico; Ortho-McNeil, United States; Santa-Farma, Turkey - Tolmetin Sodium
Actavis, United States; Mutual, United States; Mylan, United States; Sandoz, United States; Teva USA, United States; URL, United States - Tolmetin
Health Chemical, Taiwan; Li Ta, Taiwan
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment